Materialise NV reports developments in additive manufacturing software, 3D printing services, and 3D-printed medical devices. The Belgium-based foreign issuer trades on Nasdaq through ADSs and has ordinary shares listed on Euronext Brussels. Company updates commonly cover operating and financial results, segment trends in Materialise Medical, Materialise Software, and Materialise Manufacturing, and the role of 3D printing solutions across healthcare, automotive, aerospace, eyewear, art and design, wearables, and consumer goods.
Recurring announcements also include earnings-call schedules, annual and extraordinary shareholder meeting actions, regulated information under Belgian market rules, voting-rights and share-count notices, and changes affecting specific activities within the company’s 3D printing portfolio.
Materialise (NASDAQ/Euronext: MTLS) reported Q2 2026 revenue of 70,073 kEUR, up 8.1% year over year, with Adjusted EBITDA rising 15.7% to 9,593 kEUR and net profit jumping to 3,331 kEUR (0.06 EUR per diluted share). Net cash increased to 74,214 kEUR despite 2,903 kEUR of Q2 share buybacks.
For H1 2026, revenue grew 3.9% to 136,349 kEUR, driven by 9.6% growth in Materialise Medical. Adjusted EBIT rose 71.4% to 6,351 kEUR and net profit reached 5,152 kEUR versus a loss in 2025. Free cash flow was 11,368 kEUR and full-year 2026 revenue guidance of 273,000–283,000 kEUR was reaffirmed, while Adjusted EBIT guidance was raised to 12,000–14,000 kEUR.
Materialise (Euronext & NASDAQ: MTLS) will release its second quarter and half-year 2026 financial results on Thursday, August 27, 2026 at 1:00 a.m. ET / 7:00 a.m. CET. Senior management will host a conference call at 8:30 a.m. ET / 2:30 p.m. CET, with live and archived webcast access via the company’s investor website.
Materialise (NASDAQ:MTLS) held its annual general meeting on 16 June 2026, with 76% of voting rights represented. Shareholders approved the 2025 statutory annual accounts, the remuneration report, and granted discharge to directors and the statutory auditor.
They resolved to carry forward EUR 11.23 million profit from 2025 plus prior profits, reappointed KPMG as statutory auditor for 2026–2028 with an annual fee up to EUR 974,208, and renewed several board mandates for one year, until the AGM to approve 2026 accounts.
Materialise (Nasdaq: MTLS) reported the results of its annual general shareholders’ meeting held on 16 June 2026. Shareholders representing 71,207,268 voting rights, a 76% attendance rate, were present or represented, and all resolutions were approved.
Key decisions included approval of the 2025 statutory annual accounts, carrying forward profit of EUR 11,232,308.80, discharge and reappointment of KPMG as statutory auditor for 2026–2028 with annual remuneration up to EUR 974,208, renewal of all director and independent director mandates for one year, and approval of a revised director remuneration structure effective 1 January 2026.
Materialise (NASDAQ:MTLS) announced it will hold its Annual General Shareholders’ Meeting on June 16, 2026 at 10:00 a.m. CET. Convening notices, the annual report, and other AGM documents are available on the company’s investor relations website.
Materialise (NASDAQ:MTLS) reported stable Q1 2026 revenue of 66,276 kEUR, improved gross margin to 57.2%, and adjusted EBIT of 2,470 kEUR. Net result was 1,820 kEUR (0.03 EUR/diluted share). Net cash rose to 72,826 kEUR. Materialise will transfer its eyewear business to management, retain a minority stake, and expects Q2 impairments related to the transaction. Full‑year 2026 guidance is reaffirmed: revenue 273,000–283,000 kEUR and adjusted EBIT 10,000–12,000 kEUR.
Materialise (Euronext & NASDAQ: MTLS) will release first quarter 2026 financial results for the period ended March 31, 2026 on Thursday, May 7, 2026 at 1:00 a.m. ET / 7:00 a.m. CET. Senior management will host a conference call the same day at 8:30 a.m. ET / 2:30 p.m. CET.
A live audio webcast will be available at http://investors.materialise.com, and the webcast will be archived on the company's investor website. Dial-in details will be provided to participants who access the conference link at least 15 minutes before the call.
Materialise (NASDAQ: MTLS) will transfer its RapidFit business to RapidFit's existing management team, creating an independent company expected to close on or around April 30, 2026. The move aims to focus Materialise investment on higher‑potential lines while enabling RapidFit to pursue customer‑centric growth.
Materialise said the transaction is not expected to affect existing customer orders or ongoing projects; financial terms were not disclosed.
Materialise (MTLS) reported Q4 2025 revenue of 70,164 kEUR (+6.8%) and full-year 2025 revenue of 267,633 kEUR (stable). Q4 adjusted EBIT was 3,980 kEUR; full-year adjusted EBIT was 10,601 kEUR. Cash totaled 133,918 kEUR and net profit for 2025 was 7,716 kEUR. The Materialise Medical segment showed strong growth, while Manufacturing revenue declined. Management announced an Euronext listing, a strategic share buyback, and 2026 guidance: revenues of 273,000–283,000 kEUR and adjusted EBIT of 10,000–12,000 kEUR.
Materialise (MTLS) will report fourth-quarter 2025 financial results on Thursday, February 19, 2026 at 2:30 a.m. ET / 8:30 a.m. CET. Senior management will host a conference call and live webcast to discuss results on the same day.
Investors can join the conference call by phone or listen to a live audio webcast at investors.materialise.com; the webcast will be archived on the company website.